NIP142

Known as: NIP-142 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2001-2011
0120012011

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
We examined the effect of NIP-142, a benzopyran compound with terminating effect on experimental atrial arrhythmia, on the KCNQ1… (More)
Is this relevant?
2010
2010
Effects of NIP-142, a benzopyran compound which terminates experimental atrial arrhythmia, on potassium channel alpha-subunits… (More)
Is this relevant?
Review
2009
Review
2009
Atrial fibrillation (AF) is the most common arrhythmia encountered in clinical practice. Rhythm control strategy for AF is… (More)
Is this relevant?
Review
2007
Review
2007
Atrial fibrillation (AF) is one of the most frequent cardiac arrhythmia and is associated with increased cardiovascular morbidity… (More)
Is this relevant?
2006
2006
Mechanisms for the atria-specific action potential-prolonging action of NIP-142 ((3R*,4S*)-4-cyclopropylamino-3,4-dihydro-2,2… (More)
Is this relevant?
2005
2005
NIP-142 is a novel benzopyran compound that was shown to prolong the atrial effective refractory period and terminate… (More)
Is this relevant?
2002
2002
The effects of a new benzopyran derivative, NIP-142, on atrial fibrillation (AF) and flutter (AFL) and on electrophysiological… (More)
  • figure 6
Is this relevant?
2001
2001
NIP-142 was shown to prolong atrial effective refractory period and to terminate atrial fibrillation and flutter in in vivo… (More)
Is this relevant?